MLAB - Mesa Laboratories, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
243.99
+7.20 (+3.04%)
At close: 4:00PM EDT

237.05 -6.94 (-2.84%)
After hours: 4:00PM EDT

Stock chart is not supported by your current browser
Previous Close 236.79
Open 236.05
Bid 243.28 x 800
Ask 247.11 x 800
Day's Range 234.07 - 244.80
52 Week Range 167.34 - 268.47
Volume 38,838
Avg. Volume 111,350
Market Cap 1.063B
Beta (3Y Monthly) 0.31
PE Ratio (TTM) 125.64
EPS (TTM) 1.94
Earnings Date Oct 29, 2019 - Nov 4, 2019
Forward Dividend & Yield 0.64 (0.27%)
Ex-Dividend Date 2019-08-29
1y Target Est 250.33
Trade prices are not sourced from all markets
  • Mesa Laboratories (NASDAQ:MLAB) Seems To Use Debt Quite Sensibly
    Simply Wall St.

    Mesa Laboratories (NASDAQ:MLAB) Seems To Use Debt Quite Sensibly

    Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

  • GlobeNewswire

    Mesa Laboratories, Inc. Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes

    Mesa Laboratories, Inc. (MLAB) (“Mesa”) today announced the pricing of concurrent underwritten public offerings of (a) 375,000 shares of its common stock at a public offering price of $210.00 per share for gross proceeds, before deducting underwriting discounts and commissions and estimated offering expenses, of approximately $78.8 million and (b) $150 million aggregate principal amount of its 1.375% convertible senior notes due 2025 (the “notes”). In addition, Mesa has granted (a) the underwriters of the common stock offering a 30-day option to purchase up to 56,250 additional shares and (b) the underwriters of the notes offering a 13-day option to purchase up to $22.5 million aggregate principal amount of additional notes. The offering of the shares is expected to result in approximately $73.9 million in net proceeds to Mesa after deducting underwriting discounts and commissions and other estimated offering expenses payable by Mesa (assuming no exercise of the underwriters’ option to purchase additional shares).

  • GlobeNewswire

    Mesa Laboratories, Inc. Announces Proposed Public Offering of Common Stock and Convertible Senior Notes

    Mesa Laboratories, Inc. (MLAB) (“Mesa”) today announced that it has commenced concurrent underwritten public offerings of 375,000 shares of its common stock and $150 million aggregate principal amount of its convertible senior notes due 2025 (the “notes”). In addition, Mesa expects to grant (a) the underwriters of the common stock offering a 30-day option to purchase up to 56,250 additional shares and (b) the underwriters of the notes offering a 13-day option to purchase up to $22.5 million aggregate principal amount of additional notes.

  • Is Mesa Laboratories, Inc.'s (NASDAQ:MLAB) 6.6% ROE Worse Than Average?
    Simply Wall St.

    Is Mesa Laboratories, Inc.'s (NASDAQ:MLAB) 6.6% ROE Worse Than Average?

    One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

  • Mesa Labs (MLAB) Beats Q1 Earnings and Revenue Estimates
    Zacks

    Mesa Labs (MLAB) Beats Q1 Earnings and Revenue Estimates

    Mesa Labs (MLAB) delivered earnings and revenue surprises of 7.18% and 2.29%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    Mesa Labs Reports Record First Quarter Revenues and Adjusted Operating Income

    LAKEWOOD, Colo., July 30, 2019 -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported record first quarter revenues and adjusted.

  • Earnings Preview: Mesa Labs (MLAB) Q1 Earnings Expected to Decline
    Zacks

    Earnings Preview: Mesa Labs (MLAB) Q1 Earnings Expected to Decline

    Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • GlobeNewswire

    MESA LABS DECLARES QUARTERLY DIVIDEND

    Mesa Laboratories, Inc. (MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock.  The dividend will be payable on September 16, 2019, to shareholders of record at the close of business on August 30, 2019. Mesa is a global technology innovator committed to solving some of the most critical quality control challenges in the pharmaceutical, healthcare, industrial safety, environmental and food and beverage industries.  Mesa offers products and services through four divisions (Sterilization and Disinfection Control, Instruments, Cold Chain Monitoring and Cold Chain Packaging) to help our customers ensure product integrity, increase patient and worker safety, and improve quality of life throughout the world.

  • Hedge Funds Have Never Been More Bullish On Mesa Laboratories, Inc. (MLAB)
    Insider Monkey

    Hedge Funds Have Never Been More Bullish On Mesa Laboratories, Inc. (MLAB)

    Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of March. At Insider Monkey, we follow nearly 750 active hedge funds and notable investors and by analyzing their 13F filings, we can determine the stocks that they are […]

  • PR Newswire

    MarketAxess Holdings Set to Join S&P 500; Axon Enterprise to Join S&P MidCap 400; Others to Join S&P SmallCap 600

    NEW YORK , June 24, 2019 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600:   S&P MidCap 400 constituent MarketAxess Holdings Inc. ...

  • Why You Should Like Mesa Laboratories, Inc.’s (NASDAQ:MLAB) ROCE
    Simply Wall St.

    Why You Should Like Mesa Laboratories, Inc.’s (NASDAQ:MLAB) ROCE

    Today we'll look at Mesa Laboratories, Inc. (NASDAQ:MLAB) and reflect on its potential as an investment. Specifically...

  • Associated Press

    Mesa Labs: Fiscal 4Q Earnings Snapshot

    The Lakewood, Colorado-based company said it had net income of 34 cents per share. Earnings, adjusted for stock option expense and amortization costs, were $1.75 per share. The quality control instruments ...

  • GlobeNewswire

    Mesa Labs Reports Record Revenues and Adjusted Operating Income for Fiscal Year 2019

    LAKEWOOD, Colo., June 03, 2019 -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported record revenues and adjusted operating income1 for.

  • Is Mesa Laboratories, Inc. (MLAB) A Good Stock To Buy?
    Insider Monkey

    Is Mesa Laboratories, Inc. (MLAB) A Good Stock To Buy?

    "Value has performed relatively poorly since the 2017 shift, but we believe challenges to the S&P 500’s dominance are mounting and resulting active opportunities away from the index are growing. At some point, this fault line will break, likely on the back of rising rates, and all investors will be reminded that the best time […]

  • The Mesa Laboratories (NASDAQ:MLAB) Share Price Has Gained 204%, So Why Not Pay It Some Attention?
    Simply Wall St.

    The Mesa Laboratories (NASDAQ:MLAB) Share Price Has Gained 204%, So Why Not Pay It Some Attention?

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and...

  • Is Mesa Laboratories, Inc.’s (NASDAQ:MLAB) Balance Sheet Strong Enough To Weather A Storm?
    Simply Wall St.

    Is Mesa Laboratories, Inc.’s (NASDAQ:MLAB) Balance Sheet Strong Enough To Weather A Storm?

    While small-cap stocks, such as Mesa Laboratories, Inc. (NASDAQ:MLAB) with its market cap of US$913m, are popular for their explosive growth, investors should also be aware of their balance sheetRead More...

  • GlobeNewswire

    Mesa Labs Announces Changes in The Composition of Its Board of Directors

    LAKEWOOD, Colo., March 06, 2019 -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) has announced several changes to the composition of its Board of.

  • Did Mesa Laboratories, Inc. (NASDAQ:MLAB) Use Debt To Deliver Its ROE Of 9.6%?
    Simply Wall St.

    Did Mesa Laboratories, Inc. (NASDAQ:MLAB) Use Debt To Deliver Its ROE Of 9.6%?

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Many investors are still learning about theRead More...

  • Mesa Labs (MLAB) Misses Q3 Earnings Estimates
    Zacks

    Mesa Labs (MLAB) Misses Q3 Earnings Estimates

    Mesa Labs (MLAB) delivered earnings and revenue surprises of -1.08% and 3.42%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Press

    Mesa Labs: Fiscal 3Q Earnings Snapshot

    On a per-share basis, the Lakewood, Colorado-based company said it had net income of 21 cents. Earnings, adjusted for asset impairment costs and amortization costs, were $1.83 per share. The quality control ...

  • GlobeNewswire

    Mesa Labs Reports Record Third Quarter Revenues and Adjusted Operating Income

    LAKEWOOD, Colo., Feb. 04, 2019 -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported record revenues and adjusted operating income for.

  • Mesa Labs (MLAB) Earnings Expected to Grow: Should You Buy?
    Zacks

    Mesa Labs (MLAB) Earnings Expected to Grow: Should You Buy?

    Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • GlobeNewswire

    Mesa's Board Announces Death of Board Member H. Stuart Campbell

    Lakewood, Colo., Jan. 08, 2019 -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that H. Stuart Campbell, Mesa’s Lead Independent.

  • GlobeNewswire

    Mesa Labs Declares Quarterly Dividend

    Mesa Laboratories, Inc. (MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock.  The dividend will be payable on March 15, 2019, to shareholders of record at the close of business on February 28, 2019. Mesa is a global technology innovator committed to solving some of the most critical quality control and analytical challenges in the pharmaceutical, healthcare, industrial safety, environmental and food & beverage industries.  Mesa offers products and services through four divisions (Sterilization and Disinfection Control, Instruments, Cold Chain Monitoring and Cold Chain Packaging) which help its customers ensure product integrity, increase patient and worker safety, and design innovative solutions that improve the quality of life throughout the world.